phenacemide

Trade name: phenurone

Small moleculeapproved

Approved

Jun 28, 1951

Phenacemide, also known as phenylacetylurea, is an anticonvulsant of the ureide (acetylurea) class. Phenacemide was introduced in 1949 for the treatment of epilepsy, but was eventually withdrawn from the market because of its severe side effects, which includes personality changes, blood, renal and skin disorders. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1950s

  1. Jun 28, 1951

    AbbVie — Earliest FDA Approval

  2. Jun 28, 1951

    AbbVie — NDA Secondary Org

  3. Jun 28, 1951

    AbbVie — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedPriority reviewJun 28, 1951

Chemistry & pharmacology

Loading structure…

SMILES

NC(=O)NC(=O)CC1=CC=CC=C1
Mol. weight
178.1879 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Parenteral, Topical
Availability
Discontinued

Oral

No

Parenteral

Yes

Topical

Yes

Black box warning

Sources

Also known as

  • benzeneacetamide, n-(aminocarbonyl)-
  • cetylureum
  • fenacemid
  • neophedan
  • phacetur
  • phenacalum
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacemide
  • phenacetur
  • phenacetylcarbamide
  • phenacetylurea
  • phenicarb
  • phenuron
  • phenuron
  • phenuron
  • phenuron
  • phenuron
  • phenuron
  • phenurone
  • phenurone
  • phenurone
  • phenurone
  • (phenylacetyl)urea
  • phetylureum

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
AbbVieFor profitNDA2Jun 28, 1951
AbbVieFor profitNDAJun 28, 1951